Fig. 5 | Scientific Reports

Fig. 5

From: Investigating the role of MYLK2 in breast cancer prognosis and assessing its clinical application value

Fig. 5

Prognostic significance of MYLK2 expression on survival outcomes. (A) Kaplan-Meier survival curves illustrating overall survival, with patients grouped by low (blue) and high (red) MYLK2 expression levels. Hazard ratio (HR) is indicated (HR = 1.39; 95% CI: 1.01–1.92; P = 0.043). (B) Progression-free interval survival analysis showing significant differences between low and high MYLK2 expression (HR = 1.43; 95% CI: 1.03–1.99; P = 0.033). (C) Disease-specific survival analysis further demonstrating worse outcomes correlated with high MYLK2 expression (HR = 1.80; 95% CI: 1.16–2.80; P = 0.009).

Back to article page